🇺🇸 FDA
Patent

US 10596247

Methods and compositions for attenuated chlamydia as vaccine and vector

granted A61KA61K2039/522A61K39/118

Quick answer

US patent 10596247 (Methods and compositions for attenuated chlamydia as vaccine and vector) held by The Board of Regents of the University of Texas System expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/522, A61K39/118